Article

Suresh Ramalingam on Side Effects Associated With Immunotherapy in Lung Cancer

Author(s):

Suresh S. Ramalingam

Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, discusses side effects associated with immunotherapy in lung cancer.

Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, discusses side effects associated with immunotherapy in lung cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Photo of Dr. Rosario Ligresti
Image of women with text.
CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.
Related Content
Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about why she remains hopeful for the future or cancer vaccines.
August 22nd 2025

Could Cancer Vaccines Become a Reality Within the Next Decade?

Kristen Dahlgren
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
August 22nd 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
August 22nd 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
image of dr. Lillian Siu.
August 22nd 2025

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

Dr Lillian Siu
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
August 22nd 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Image of Dr. Fakih.
August 22nd 2025

ctDNA Alone ‘Not Sufficient’ When Monitoring Patients With Colorectal Cancer

Dr. Marwan Fakih